Browsing: Brain

Gout and dementia – the controversy continues

By 0
Gout [1] is one of the most common causes of inflammatory arthritis worldwide, characterised by urate crystal deposition in the joint spaces.  Previously recognized complications of gout include tophi, joint deformity, bone loss; renal disease such as nephrolithiasis, and ocular diseases such as conjunctivitis, uveitis, or scleritis [2]. 

Log In or Register as a healthcare professional to read the full article.

Rising Expectations for Alzheimer’s Disease Treatment in Japan

By 1

A novel Alzheimer’s disease treatment drug, lecanemab, developed by Japanese pharmaceutical company Eisai and US firm Biogen, is nearing full approval in the US. Excitement is also building in Japan where the population of Alzheimer’s patients is growing and Prime Minister Fumio Kishida has prioritised dementia. The drug is undergoing an expedited review by the Japanese Pharmaceuticals and Medical Devices Agency and could potentially be approved this autumn.